Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for InMode Ltd. (INMD : NSDQ)
 
 • Company Description   
InMode Ltd. is a provider of medical technologies. It develops, manufactures and markets devices harnessing novel radio-frequency technology. The company serves plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. InMode Ltd. is based in Yokneam, Israel.

Number of Employees: 599

 
 • Price / Volume Information   
Yesterday's Closing Price: $15.36 Daily Weekly Monthly
20 Day Moving Average: 1,715,685 shares
Shares Outstanding: 63.21 (millions)
Market Capitalization: $970.89 (millions)
Beta: 1.95
52 Week High: $19.85
52 Week Low: $13.14
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.49% 2.33%
12 Week -0.29% -13.57%
Year To Date -8.02% -13.10%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
TAVOR BUILDING SHAAR YOKNEAM POB 533
-
YOKNEAM,L3 2069200
ISR
ph: 972-4909-7470
fax: -
ir@inmodemd.com http://www.inmodemd.com
 
 • General Corporate Information   
Officers
Moshe Mizrahy - Chief Executive Officer
Michael Anghel - Chairman
Yair Malca - Chief Financial Officer
Bruce Mann - Director
Nadav Kenneth - Director

Peer Information
InMode Ltd. (BJCT)
InMode Ltd. (CADMQ)
InMode Ltd. (APNO)
InMode Ltd. (UPDC)
InMode Ltd. (IMTIQ)
InMode Ltd. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: M5425M103
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/07/25
Share - Related Items
Shares Outstanding: 63.21
Most Recent Split Date: 10.00 (2.00:1)
Beta: 1.95
Market Capitalization: $970.89 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.41 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $1.63 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/07/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 9.42
Trailing 12 Months: 9.78
PEG Ratio: -
Price Ratios
Price/Book: 1.57
Price/Cash Flow: 8.42
Price / Sales: 2.47
EPS Growth
vs. Year Ago Period: -36.59%
vs. Previous Quarter: -31.58%
Sales Growth
vs. Year Ago Period: -3.00%
vs. Previous Quarter: -20.42%
ROE
06/30/25 - -
03/31/25 - 17.17
12/31/24 - 18.25
ROA
06/30/25 - -
03/31/25 - 15.20
12/31/24 - 16.33
Current Ratio
06/30/25 - -
03/31/25 - 8.73
12/31/24 - 10.23
Quick Ratio
06/30/25 - -
03/31/25 - 7.86
12/31/24 - 9.38
Operating Margin
06/30/25 - -
03/31/25 - 30.74
12/31/24 - 34.76
Net Margin
06/30/25 - -
03/31/25 - 44.79
12/31/24 - 45.91
Pre-Tax Margin
06/30/25 - -
03/31/25 - 35.64
12/31/24 - 36.34
Book Value
06/30/25 - -
03/31/25 - 8.91
12/31/24 - 10.12
Inventory Turnover
06/30/25 - -
03/31/25 - 1.34
12/31/24 - 1.40
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©